ARCHIVES

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Dipersio Is Chief Of Oncology At Washington University.

July 14, 2000

Biostatistician Thomas Fleming Warns Against Approval of Provenge.

May 4, 2007

In Brief: Fabien Calvo named chief scientific officer of Cancer Core Europe

December 19, 2014

Clinical Trials, Centers Would Be First In Line For Money Added To Budget, Broder Tells Congress

March 31, 1989

Shubik Warns NCA Members They May Be Prober’s Next Target

May 22, 1981

Clinical Sciences Director Liu To Head Singapore Program.

January 12, 2001